The Medicines for Human Use (Clinical Trials) Regulations 2004: what changed
468 changes of wording, as read on 19 Nov 2026.
The latest 200 of 468.
140
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 2 · Interpretation
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 3 · Sponsor of a clinical trial
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, 3b · Investigator in a clinical trial
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 5 · United Kingdom Ethics Committees Authority
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 6 · Establishment and abolition of ethics committees
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 7 · Recognition of ethics committees
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 8 · Revocation of recognition
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 9 · Operation of ethics committees
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 11 · Interpretation of Part 3
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, 11a · Definition of notifiable trial
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, 11b · Definition of Route B substantial modification
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 12 · Requirement for authorisation and ethics committee opinion
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 13 · Supply of investigational medicinal products for the purpose of clinical trials
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 14 · Request for authorisation to conduct a clinical trial
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 15 · Application for ethics committee opinion
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 16 · Request for approval and combined procedure
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 17 · Assessment of request for approval
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 18 · Approval procedure for clinical trials
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, 18a · Request for further information regarding a request for approval
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, 18b · Approval procedure for amended requests for approval
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, 18c · Approval procedure time periods in special circumstances
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 19 · Clinical trials conducted in countries other than the United Kingdom
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 20 · Modifications to clinical trial approval
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 21 · Modifications by the licensing authority or the ethics committee
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 22 · Modifications by the sponsor
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, 22a · Approval procedure for substantial modifications
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, 22b · Request for further information regarding proposed substantial modifications
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, 22c · Approval procedure for amended requests regarding substantial modifications
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 23 · Reference to the appropriate committee or the Medicines Commission
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 24 · Review and appeal relating to ethics committee opinion
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 25 · Transparency requirements
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 26 · Lapse of clinical trial approval
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 27a · Information sharing
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 27b · Publication of information
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 28 · Good clinical practice and protection of clinical trial participants
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 29 · Conduct of trial in accordance with clinical trial authorisation etc.
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 29a · Notification of serious breaches
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 30 · Urgent safety measures
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 31 · Suspension or termination of clinical trial
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 31a · Trial master file and archiving
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, a32 · Record keeping
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 32 · Notification of adverse events
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 33 · Notification of suspected unexpected serious adverse reactions
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 35 · Annual … safety report
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 36 · Requirement for authorisation to manufacture or import investigational medicinal products
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, 37a · Exemption for radiopharmaceuticals used for diagnostic purposes
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 40 · Grant or refusal of manufacturing authorisation
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 43 · Qualified persons
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, 45a · Non-investigational medicinal and non-medicinal products
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 46 · Labelling of investigational medicinal products
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, 46a · Labelling of non-investigational medicinal products
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, 46b · Labelling of certain POC investigational medicinal products
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 48 · Infringement notices
- amended
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 50 · False or misleading information
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 56 · Transitional provisions
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 58 · Detailed guidance
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- repealed
Medicines for Human Use (Clinical Trials) Regulations 2004, Sch. 1, para. 5
- repealed
Medicines for Human Use (Clinical Trials) Regulations 2004, Sch. 1, para. 6
- repealed
Medicines for Human Use (Clinical Trials) Regulations 2004, Sch. 1, para. 7
- repealed
Medicines for Human Use (Clinical Trials) Regulations 2004, Sch. 1, para. 8
- repealed
Medicines for Human Use (Clinical Trials) Regulations 2004, Sch. 1, para. 9
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, Sch. 2, para. 7 · Deputies and co-opted members
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- new
- new
- new
- new
- new
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, Sch. 5, para. 1 · Hearing before the appropriate committee
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, Sch. 5, para. 2 · Licensing authority decision
- new
- amended
- amended
- amended
- amended
- amended
- amended
- new
- new
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, Sch. 14, para. 2 · Application of the old rules to the authorisation etc of existing clinical trials
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, Sch. 14, para. 3 · Application of Good Clinical Practice to old rules clinical trials
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, Sch. 14, para. 4 · Pharmacovigilance in respect of old rules clinical trials
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, Sch. 14, para. 5 · Manufacture and importation of investigational medicinal products used in old rules clinical trials
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, Sch. 14, para. 6 · Labelling of investigational medicinal products used in old rules clinical trials
- new
42
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 2 · Interpretation
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 13 · Supply of investigational medicinal products for the purpose of clinical trials
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 36 · Requirement for authorisation to manufacture or import investigational medicinal products
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, 36a · Manufacture of MM investigational medicinal products
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, 36b · Manufacture of POC investigational medicinal products
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 39 · Consideration of application for manufacturing authorisation
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 41 · Application and effect of manufacturing authorisation
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 44 · Variation of manufacturing authorisation
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, 44a · Variation of MM (IMP) master file
- new
Medicines for Human Use (Clinical Trials) Regulations 2004, 44b · Variation of POC (IMP) master file
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 45 · Suspension and revocation of manufacturing authorisation
- amended
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 48 · Infringement notices
- amended
- amended
- amended
- amended
- new
- new
- amended
- amended
- new
- new
- amended
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
1
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 2 · Interpretation
1
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 2 · Interpretation
3
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 2 · Interpretation
- amended
- amended
13
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 2 · Interpretation
- amended
Medicines for Human Use (Clinical Trials) Regulations 2004, 43 · Qualified persons
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- amended
- new
- amended
- amended